[Skip to Content]
[Skip to Content Landing]
Article
July 1983

Comparison of Ocular Disposition of Free Pivalic Acid and Pivalic Acid Esterified in Dipivefrin

Author Affiliations

From the Department of Ophthalmology, California College of Medicine, University of California (Drs Tamaru and Anderson), and the Biochemistry Section, Allergan Pharmaceuticals (Ms Davis and Dr Anderson), Irvine, Calif.

Arch Ophthalmol. 1983;101(7):1127-1129. doi:10.1001/archopht.1983.01040020129023
Abstract

• Dipivefrin, a diester of pivalic acid and epinephrine that is used in the treatment of glaucoma, has been shown to be hydrolyzed in the cornea, and the ocular pharmacokinetics of the active moiety, epinephrine, have been determined. A comparison of the ocular disposition of the pivalic acid released by hydrolysis of dipivefrin and that of topically applied free pivalic acid showed that the released pivalic acid is not metabolized in the eye and is rapidly eliminated from the eye with no apparent sequestration in ocular tissues. In addition, results of two methods for preparing ocular tissues for analysis of drug distribution indicated that freezing and thawing processes can lead to redistribution of materials in ocular tissues.

×